Cryo-ablation management of atrial fibrillation in Fabry disease without agalsidase alpha: a case report
Fabry disease (FD) is a rare genetic disorder caused by mutations in the GLA gene, affecting multiple organs. Over 60% of patients experience heart-related issues, primarily arrhythmias. Unlike typical cases, these arrhythmias are complex and often do not respond well to standard antiarrhythmic drug...
Saved in:
| Main Authors: | Yuanzhu Li, Bi Huang, Suxin Luo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1483283/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cryptogenic strokes and neurological symptoms of Fabry disease
by: Maria Luisa Ruiz-Franco, et al.
Published: (2025-03-01) -
Shortened PQ interval in the differential diagnosis of Anderson-Fabry disease: a case report
by: P. D. Zlobina, et al.
Published: (2022-08-01) -
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study
by: Daniele Di Natale, et al.
Published: (2025-02-01) -
A multi-country time and motion study to describe the experience and burden associated with the treatment of Fabry disease with enzyme replacement therapy with agalsidase alfa and agalsidase beta
by: Ian Keyzor, et al.
Published: (2025-08-01) -
Pulsed‐Field Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation: A Systematic Review and Meta‐Analysis
by: Inês Martins Esteves, et al.
Published: (2025-08-01)